Rocket Pharmaceuticals (RCKT) shares were down over 2% in recent Tuesday trading after JPMorgan downgraded the stock to underweight from neutral.
Trading volume was more than 2.4 million shares, compared with a daily average of about 3.6 million.
Price: 2.97, Change: -0.08, Percent Change: -2.47